Literature DB >> 17395259

Methylenetetrahydrofolate reductase (MTHFR) C677T and thymidylate synthase promoter (TSER) polymorphisms in Indonesian children with and without leukemia.

Elisa Giovannetti1, Dewa G Ugrasena, Eddy Supriyadi, Laura Vroling, Antonino Azzarello, Desiree de Lange, Godefridus J Peters, Anjo J P Veerman, Jacqueline Cloos.   

Abstract

Genetic variations in the polymorphic tandem repeat sequence of the enhancer region of the thymidylate synthase promoter (TSER), as well as in methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism, influence methotrexate sensitivity. We studied these polymorphisms in children with acute lymphoblastic leukaemia (ALL) and in subjects without malignancy in Indonesia and Holland. The frequencies of TT and CT genotypes were two-fold higher in Dutch children. The TSER 3R/3R repeat was three-fold more frequent in the Indonesian children, while the 2R/2R repeat was only 1% compared to 21% in the Dutch children. No differences of these polymorphisms were found between ALL cells and normal blood cells, indicating an ethnic rather than leukemic origin. These results may have implications for treatment of Indonesian children with ALL.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17395259     DOI: 10.1016/j.leukres.2007.02.011

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  15 in total

Review 1.  Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: a systematic review and meta-analysis.

Authors:  Jayaram Vijayakrishnan; Richard S Houlston
Journal:  Haematologica       Date:  2010-05-29       Impact factor: 9.941

Review 2.  Identifying genetic variants that contribute to chemotherapy-induced cytotoxicity.

Authors:  Christine M Hartford; M Eileen Dolan
Journal:  Pharmacogenomics       Date:  2007-09       Impact factor: 2.533

3.  Thymidylate synthase and methionine synthase polymorphisms are not associated with susceptibility to childhood acute lymphoblastic leukemia in Kurdish population from Western Iran.

Authors:  Zohreh Rahimi; Zainab Ahmadian; Reza Akramipour; Asad Vaisi-Raygani; Ziba Rahimi; Abbas Parsian
Journal:  Mol Biol Rep       Date:  2011-06-05       Impact factor: 2.316

4.  Comparative pharmacogenetic analysis of risk polymorphisms in Caucasian and Vietnamese children with acute lymphoblastic leukemia: prediction of therapeutic outcome?

Authors:  Phuong Thu Vu Hoang; Jérôme Ambroise; Anne-France Dekairelle; Jean-François Durant; Valentina Butoescu; Vu Luan Dang Chi; Nghia Huynh; Tan Binh Nguyen; Annie Robert; Christiane Vermylen; Jean-Luc Gala
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

Review 5.  A literature review of MTHFR (C677T and A1298C polymorphisms) and cancer risk.

Authors:  Muzeyyen Izmirli
Journal:  Mol Biol Rep       Date:  2012-10-19       Impact factor: 2.316

Review 6.  Genetic susceptibility to childhood leukaemia.

Authors:  Anand P Chokkalingam; Patricia A Buffler
Journal:  Radiat Prot Dosimetry       Date:  2008-10-15       Impact factor: 0.972

7.  MTHFR gene polymorphism in acute lymphoblastic leukemia among North Indian children: a case-control study and meta-analysis updated from 2011.

Authors:  Nirmalya Roy Moulik; Farah Parveen; Archana Kumar; Shally Awasthi; Suraksha Agrawal
Journal:  J Hum Genet       Date:  2014-06-12       Impact factor: 3.172

8.  The prevalence and clinical relevance of 2R/2R TYMS genotype in patients with gastrointestinal malignancies treated with fluoropyrimidine-based chemotherapy regimens.

Authors:  Moh'd Khushman; Girijesh Kumar Patel; Anu Singh Maharjan; Gwendolyn A McMillin; Cindy Nelson; Peter Hosein; Ajay P Singh
Journal:  Pharmacogenomics J       Date:  2021-02-19       Impact factor: 3.550

9.  Methylenetetrahydrofolate reductase polymorphisms and risk of acute lymphoblastic leukemia-evidence from an updated meta-analysis including 35 studies.

Authors:  Haigang Wang; Jiali Wang; Lixia Zhao; Xinchun Liu; Wenjie Mi
Journal:  BMC Med Genet       Date:  2012-09-04       Impact factor: 2.103

10.  Pemetrexed induced thymidylate synthase inhibition in non-small cell lung cancer patients: a pilot study with 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography.

Authors:  Virginie Frings; Astrid A M van der Veldt; Ronald Boellaard; Gerarda J M Herder; Elisa Giovannetti; Richard Honeywell; Godefridus J Peters; Erik Thunnissen; Otto S Hoekstra; Egbert F Smit
Journal:  PLoS One       Date:  2013-05-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.